372 related articles for article (PubMed ID: 32486152)
21. Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells.
Bulcaen M; Kortleven P; Liu RB; Maule G; Dreano E; Kelly M; Ensinck MM; Thierie S; Smits M; Ciciani M; Hatton A; Chevalier B; Ramalho AS; Casadevall I Solvas X; Debyser Z; Vermeulen F; Gijsbers R; Sermet-Gaudelus I; Cereseto A; Carlon MS
Cell Rep Med; 2024 May; 5(5):101544. PubMed ID: 38697102
[TBL] [Abstract][Full Text] [Related]
22. New treatments targeting the basic defects in cystic fibrosis.
Fajac I; Wainwright CE
Presse Med; 2017 Jun; 46(6 Pt 2):e165-e175. PubMed ID: 28554723
[TBL] [Abstract][Full Text] [Related]
23. Correctors (specific therapies for class II CFTR mutations) for cystic fibrosis.
Southern KW; Patel S; Sinha IP; Nevitt SJ
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010966. PubMed ID: 30070364
[TBL] [Abstract][Full Text] [Related]
24. Perspectives on Genetic Medicine for Cystic Fibrosis.
Smirnikhina SA
Curr Gene Ther; 2022; 22(5):386-396. PubMed ID: 35864800
[TBL] [Abstract][Full Text] [Related]
25. Non-Modulator Therapies: Developing a Therapy for Every Cystic Fibrosis Patient.
Egan ME
Clin Chest Med; 2022 Dec; 43(4):717-725. PubMed ID: 36344076
[TBL] [Abstract][Full Text] [Related]
26. Targeting the Root Cause of Cystic Fibrosis.
Trescott L; Holcomb J; Spellmon N; Mcleod C; Aljehane L; Sun F; Li C; Yang Z
Curr Drug Targets; 2015; 16(9):933-44. PubMed ID: 25316272
[TBL] [Abstract][Full Text] [Related]
27. Emerging gene therapies for cystic fibrosis.
Miah KM; Hyde SC; Gill DR
Expert Rev Respir Med; 2019 Aug; 13(8):709-725. PubMed ID: 31215818
[No Abstract] [Full Text] [Related]
28. Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing.
Maule G; Casini A; Montagna C; Ramalho AS; De Boeck K; Debyser Z; Carlon MS; Petris G; Cereseto A
Nat Commun; 2019 Aug; 10(1):3556. PubMed ID: 31391465
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic pipeline for individuals with cystic fibrosis with mutations nonresponsive to current cystic fibrosis transmembrane conductance regulator modulators.
Fajac I; Sermet-Gaudelus I
Curr Opin Pulm Med; 2021 Nov; 27(6):567-574. PubMed ID: 34494979
[TBL] [Abstract][Full Text] [Related]
30. Evaluating CRISPR-based prime editing for cancer modeling and CFTR repair in organoids.
Geurts MH; de Poel E; Pleguezuelos-Manzano C; Oka R; Carrillo L; Andersson-Rolf A; Boretto M; Brunsveld JE; van Boxtel R; Beekman JM; Clevers H
Life Sci Alliance; 2021 Oct; 4(10):. PubMed ID: 34373320
[TBL] [Abstract][Full Text] [Related]
31. Advances in gene therapy for cystic fibrosis lung disease.
Yan Z; McCray PB; Engelhardt JF
Hum Mol Genet; 2019 Oct; 28(R1):R88-R94. PubMed ID: 31332440
[TBL] [Abstract][Full Text] [Related]
32. TALEN-Mediated Gene Targeting for Cystic Fibrosis-Gene Therapy.
Xia E; Zhang Y; Cao H; Li J; Duan R; Hu J
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30641980
[TBL] [Abstract][Full Text] [Related]
33. Powerful tools for genetic modification: Advances in gene editing.
Roesch EA; Drumm ML
Pediatr Pulmonol; 2017 Nov; 52(S48):S15-S20. PubMed ID: 28960896
[TBL] [Abstract][Full Text] [Related]
34. Will Airway Gene Therapy for Cystic Fibrosis Improve Lung Function? New Imaging Technologies Can Help Us Find Out.
Parsons D; Donnelley M
Hum Gene Ther; 2020 Sep; 31(17-18):973-984. PubMed ID: 32718206
[TBL] [Abstract][Full Text] [Related]
35. A new era of personalized medicine for cystic fibrosis - at last!
Quon BS; Wilcox PG
Can Respir J; 2015; 22(5):257-60. PubMed ID: 26083544
[TBL] [Abstract][Full Text] [Related]
36. Recombinant Adeno-Associated Virus-Mediated Editing of the G551D Cystic Fibrosis Transmembrane Conductance Regulator Mutation in Ferret Airway Basal Cells.
Yan Z; Vorhies K; Feng Z; Park SY; Choi SH; Zhang Y; Winter M; Sun X; Engelhardt JF
Hum Gene Ther; 2022 Oct; 33(19-20):1023-1036. PubMed ID: 35686451
[TBL] [Abstract][Full Text] [Related]
37. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
38. Phenotypic Characterization and Comparison of Cystic Fibrosis Rat Models Generated Using CRISPR/Cas9 Gene Editing.
McCarron A; Cmielewski P; Reyne N; McIntyre C; Finnie J; Craig F; Rout-Pitt N; Delhove J; Schjenken JE; Chan HY; Boog B; Knight E; Gilmore RC; O'Neal WK; Boucher RC; Parsons D; Donnelley M
Am J Pathol; 2020 May; 190(5):977-993. PubMed ID: 32084371
[TBL] [Abstract][Full Text] [Related]
39. Recent advances in developing therapeutics for cystic fibrosis.
Strug LJ; Stephenson AL; Panjwani N; Harris A
Hum Mol Genet; 2018 Aug; 27(R2):R173-R186. PubMed ID: 30060192
[TBL] [Abstract][Full Text] [Related]
40. Delivery of genes into the CF airway.
Gill DR; Hyde SC
Thorax; 2014 Oct; 69(10):962-4. PubMed ID: 25015239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
